Nanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT™ nanoparticles

Journal of Controlled Release

Volumn 121, Issue 1-2, 2007, Pages 10-18

  Gratton, Stephanie E A ^a   Pohlhaus, Patrick D ^a   Lee, Jin ^b   Guo, Ji ^a   Cho, Moo J ^b   DeSimone, Joseph M ^a,b,c,d  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c North Carolina State University   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Biodistribution; Nanomedicine; Nanoparticles; Pharmacokinetics; PRINT

Indexed keywords

BIODISTRIBUTION; NANOMEDICINES; PERFLUOROPOLYETHER NETWORK;

INTERFACIAL ENERGY; LITHOGRAPHY; NANOPARTICLES; NANOTECHNOLOGY;

PHARMACOKINETICS;

DENDRIMER; DRUG CARRIER; ELASTOMER; FLUOROCUR; IODINE 125; LIPOSOME; MACROGOL; NANOPARTICLE; ORGANIC COMPOUND; PERFLUORO COMPOUND; POLYETHER DERIVATIVE; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL COMPOSITION; COLLOID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; ENERGY; HELA CELL; HUMAN; HUMAN CELL; LIGHT SCATTERING; LITHOGRAPHY; MACROMOLECULE; MATERIAL COATING; MOUSE; NANOENGINEERING; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PARTICLE REPLICATION IN NONWETTING TEMPLATE; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TECHNIQUE; TUBE;

ACRYLATES; ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG THERAPY; ETHERS; FLUOROCARBONS; IODINE RADIOISOTOPES; LIGHT; LIPOSOMES; MICE; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; PHARMACOKINETICS; POLYETHYLENE GLYCOLS; PROPYLENE GLYCOLS; SCATTERING, RADIATION; STYRENES; TISSUE DISTRIBUTION;

EID: 34547216961     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.05.027     Document Type: Article

References (34)

1. Riley S. Innovation in drug delivery: the future of nanotechnology and non-invasive protein delivery. Bus. Insights Ltd. (2006) 25-26
2. Moghimi S.M., Hunter A.C., and Murray J.C. Nanomedicine: current status and future prospects. FASEB J. 19 3 (2005) 311-330
3. Barenholz Y. Liposome application: problems and prospects. Curr. Opin. Colloid Interface Sci. 6 1 (2001) 66-77
4. Kwon G.S., and Kataoka K. Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Deliv. Rev. 16 (1995) 295-309
5. Lee C.C., MacKay J.A., Frechet J.M.J., and Szoka F.C. Designing dendrimers for biological applications. Nat. Biotechnol. 23 12 (2005) 1517-1526
6. Torchilin V.P. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell. Mol. Life Sci. 61 (2004) 2549-2559
7. Vicent M.J., and Duncan R. Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol. 24 1 (2006) 39-47
8. Duncan R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2 5 (2003) 347-360
9. McAllister K., Sazani P., Adam M., Cho M.J., Rubinstein M., Samulski R.J., and DeSimone J.M. Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents. J. Am. Chem. Soc. 124 51 (2002) 15198-15207
10. Rolland J.P., Maynor B.W., Euliss L.E., Exner A.E., Denison G.M., and DeSimone J.M. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc. 127 28 (2005) 10096-10100
11. Rolland J.P., Hagberg E.C., Denison G.M., Carter K.R., and DeSimone J.M. High-resolution soft lithography: enabling materials for nanotechnologies. Angew. Chem., Int. Ed. Engl. 43 43 (2004) 5796-5799
12. Euliss L.E., DuPont J.A., Gratton S., and DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev. 35 11 (2006) 1095-1104
13. Patt Y.N., Patel S.J., Evers M., Friendly D.H., and Stark J. One billion transistors, one uniprocessor, one chip. Computer 30 9 (1997) 51-57
14. Hiremane R. From Moore's Law to Intel Innovation-prediction to reality. Technology@Intel Magazine (2005) 2-9
15. Baker T.S., Olson N.H., and Fuller S.D. Adding the third dimension to virus life cycles: three-dimensional reconstruction of icosahedral viruses from cryo-electron micrographs. Microbiol. Mol. Biol. Rev. 63 4 (1999) 862-922
16. www.intel.com, 1/22/07.
17. Huang Z., Guo X., Li W., MacKay J.A., and Szoka Jr. F.C. Acid-triggered transformation of diortho ester phosphocholine liposome. J. Am. Chem. Soc. 128 1 (2006) 60-61
18. Grit M., and Crommelin D.J.A. The effect of aging on the physical stability of liposome dispersions. Chem. Phys. Lipids 62 2 (1992) 113-122
19. Woodle M.C. Controlling liposome blood clearance by surface-grafted polymers. Adv. Drug Deliv. Rev. 32 (1998) 139-152
20. Papisov M.I. Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions. Adv. Drug Deliv. Rev. 32 (1998) 119-138
21. Allen T.M., Hansen C.B., and de Menezes D.E.L. Pharmacokinetics of long-circulating liposomes. Adv. Drug Deliv. Rev. 16 (1995) 267-284
22. Gregoriadis G. Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol. 13 12 (1995) 527-537
23. Torchilin V.P. Polymer-coated long-circulating microparticulate pharmaceuticals. J. Microencapsul 15 1 (1998) 1-19
24. Barltrop J.A., Owen T.C., Cory A.H., and Cory J.G. 5-(3-Carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators. Bioorg. Med. Chem. Lett. 1 11 (1991) 611-614
25. Wisse E., and De Leeus A.M. In: Davis S.S., Illum L., McVie J.G., and Tomlinson E. (Eds). Structural Elements Determining Transport and Exchange Processes in the Liver (1984), Elsevier Scientific, Amsterdam 1-23
26. Senior J.H. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carr. Syst. 3 2 (1987) 123-193
27. Chonn A., Semple S.C., and Cullis P.R. β2-glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J. Biol. Chem. 270 43 (1995) 25845-25849
28. Wolf H., Marschall F., Scheffold N., Clausen M., Schramm M., and Henze E. Iodine-123 labelling of atrial natriuretic peptide and its analogs: initial results. Eur. J. Nucl. Med. Mol. Imaging 20 4 (1993) 297-301
29. Takakura Y., and Hashida M. Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm. Res. 13 6 (1996) 820-831
30. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53 2 (2001) 283-318
31. Owens D.E., and Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307 1 (2006) 93-102
32. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., and Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51 4 (1999) 691-743
33. Allen T.M., and Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta 1068 2 (1991) 133-141
34. Kataoka K., Matsumoto T., Yokoyama M., Okano T., Sakurai Y., Fukushima S., Okamoto K., and Kwon G.S. Doxorubicin-loaded poly(ethylene glycol)-poly(b-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control. Release 64 (2000) 143-153